The 2024 agenda looks at ongoing regulations, end-to-end artwork, sustainability, serialization, e-labelling and patient safety. Top pharmaceutical companies, biotechs, CMOs and regulatory bodies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results